LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences.

    Görzer, I / Buchta, Ch / Chiba, P / Benka, B / Camp, J V / Holzmann, H / Puchhammer-Stöckl, E / Aberle, S W

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

    2020  Volume 129, Page(s) 104537

    Abstract: ... The objective of this study was to monitor reliability of the laboratory results for SARS-CoV-2 RNA detection ... through an external quality assessment (EQA) scheme.: Methods: For this, the Center for Virology, Medical ... Consumer Protection to perform the first Austrian EQA on SARS-CoV-2 which was organised in cooperation ...

    Abstract Background: Broad and decentralised testing of SARS-CoV-2 RNA genomes is a WHO-recommended strategy to contain the SARS-CoV-2 pandemic by identifying infected cases in order to minimize onward transmission. With the need to increase the test capacities in Austria, nation-wide numerous laboratories rapidly implemented assays for molecular detection of SARS-CoV-2 based on real-time RT-PCR assays. The objective of this study was to monitor reliability of the laboratory results for SARS-CoV-2 RNA detection through an external quality assessment (EQA) scheme.
    Methods: For this, the Center for Virology, Medical University of Vienna was tasked by the Federal Ministry of Social Affairs, Health, Care and Consumer Protection to perform the first Austrian EQA on SARS-CoV-2 which was organised in cooperation with the Austrian Association for Quality Assurance and Standardization of Medical and Diagnostic Tests (ÖQUASTA). Data were analysed on the basis of qualitative outcome of testing in relation to the nucleic acid (NA) extraction and detection methods used.
    Results and conclusion: A total of 52 laboratories participated, contributing results from 67 test panels comprising 42 distinct combinations of NA extraction and PCR reagents. By testing 3 positive (CT values: S1, 28.4; S2, 33.6; S3, 38.5) and 1 negative sample, no false-positive results were obtained by any of the laboratories. Otherwise, 40/67 tests (60 %) detected all positive samples correctly as positive, but 25/67 tests (37 %) did not detect the weakest positive sample (S3), and 3 % reported S2 and S3 as false-negative. Improvement in test sensitivity by focusing on NA extraction and/or PCR-based detection is recommended.
    MeSH term(s) Austria ; Betacoronavirus/isolation & purification ; COVID-19 ; COVID-19 Testing ; COVID-19 Vaccines ; Clinical Laboratory Techniques/methods ; Clinical Laboratory Techniques/standards ; Coronavirus Infections/diagnosis ; Diagnostic Errors/statistics & numerical data ; Humans ; Laboratory Proficiency Testing/organization & administration ; Molecular Diagnostic Techniques/methods ; Molecular Diagnostic Techniques/standards ; Pandemics ; Pneumonia, Viral/diagnosis ; Real-Time Polymerase Chain Reaction/methods ; Real-Time Polymerase Chain Reaction/standards ; SARS-CoV-2 ; Sensitivity and Specificity
    Chemical Substances COVID-19 Vaccines ; Covid-19 aAPC vaccine
    Keywords covid19
    Language English
    Publishing date 2020-07-06
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1446080-4
    ISSN 1873-5967 ; 1386-6532
    ISSN (online) 1873-5967
    ISSN 1386-6532
    DOI 10.1016/j.jcv.2020.104537
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences

    Görzer, I. / Buchta, Ch. / Chiba, P. / Benka, B. / Camp, J.V. / Holzmann, H. / Puchhammer-Stöckl, E. / Aberle, S.W.

    Journal of Clinical Virology

    2020  Volume 129, Page(s) 104537

    Keywords Virology ; Infectious Diseases ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 1446080-4
    ISSN 1873-5967 ; 1386-6532
    ISSN (online) 1873-5967
    ISSN 1386-6532
    DOI 10.1016/j.jcv.2020.104537
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences

    Görzer, I / Buchta, Ch / Chiba, P / Benka, B / Camp, J V / Holzmann, H / Puchhammer-Stöckl, E / Aberle, S W

    J Clin Virol

    Abstract: ... of this study was to monitor reliability of the laboratory results for SARS-CoV-2 RNA detection ... through an external quality assessment (EQA) scheme. METHODS: For this, the Center for Virology, Medical University ... to perform the first Austrian EQA on SARS-CoV-2 which was organised in cooperation with the Austrian ...

    Abstract BACKGROUND: Broad and decentralised testing of SARS-CoV-2 RNA genomes is a WHO-recommended strategy to contain the SARS-CoV-2 pandemic by identifying infected cases in order to minimize onward transmission. With the need to increase the test capacities in Austria, nation-wide numerous laboratories rapidly implemented assays for molecular detection of SARS-CoV-2 based on real-time RT-PCR assays. The objective of this study was to monitor reliability of the laboratory results for SARS-CoV-2 RNA detection through an external quality assessment (EQA) scheme. METHODS: For this, the Center for Virology, Medical University of Vienna was tasked by the Federal Ministry of Social Affairs, Health, Care and Consumer Protection to perform the first Austrian EQA on SARS-CoV-2 which was organised in cooperation with the Austrian Association for Quality Assurance and Standardization of Medical and Diagnostic Tests (ÖQUASTA). Data were analysed on the basis of qualitative outcome of testing in relation to the nucleic acid (NA) extraction and detection methods used. RESULTS AND CONCLUSION: A total of 52 laboratories participated, contributing results from 67 test panels comprising 42 distinct combinations of NA extraction and PCR reagents. By testing 3 positive (CT values: S1, 28.4; S2, 33.6; S3, 38.5) and 1 negative sample, no false-positive results were obtained by any of the laboratories. Otherwise, 40/67 tests (60 %) detected all positive samples correctly as positive, but 25/67 tests (37 %) did not detect the weakest positive sample (S3), and 3 % reported S2 and S3 as false-negative. Improvement in test sensitivity by focusing on NA extraction and/or PCR-based detection is recommended.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #633879
    Database COVID19

    Kategorien

To top